These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1660107

  • 1. Oral opioids in the treatment of cancer pain.
    Zylicz Z, Twycross RG.
    Neth J Med; 1991 Aug; 39(1-2):108-14. PubMed ID: 1660107
    [Abstract] [Full Text] [Related]

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Aug; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 3. Experience with a controlled-release oral morphine for cancer pain management.
    Kim BS, Chung HC.
    Postgrad Med J; 1991 Aug; 67 Suppl 2():S82-6. PubMed ID: 1758823
    [Abstract] [Full Text] [Related]

  • 4. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY, Qiu H, Ma ZS, Chen J, Zhang Y, Chen LZ, Wang DL, Ma ZY.
    Zhonghua Yi Xue Za Zhi; 2004 Mar 17; 84(6):450-5. PubMed ID: 15061959
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Guidelines for the use of MS Contin tablets in the management of cancer pain.
    Warfield CA.
    Postgrad Med J; 1991 Mar 17; 67 Suppl 2():S9-12; discussion S13. PubMed ID: 1758825
    [Abstract] [Full Text] [Related]

  • 9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, Villari P, Ficorella C, Gebbia V, Riina S, Casuccio A, Mangione S.
    Eur J Pain; 2008 Nov 17; 12(8):1040-6. PubMed ID: 18353696
    [Abstract] [Full Text] [Related]

  • 10. [Cancer pain therapy in children and adolescents using morphine].
    Sittl R, Richter R.
    Anaesthesist; 1991 Feb 17; 40(2):96-9. PubMed ID: 2048710
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan 17; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dextropropoxyphene versus morphine in opioid-naive cancer patients with pain.
    Mercadante S, Salvaggio L, Dardanoni G, Agnello A, Garofalo S.
    J Pain Symptom Manage; 1998 Feb 17; 15(2):76-81. PubMed ID: 9494305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Use of oral morphine in incurable pain].
    Twycross R, Zenz M.
    Anaesthesist; 1983 Jun 17; 32(6):279-83. PubMed ID: 6614416
    [Abstract] [Full Text] [Related]

  • 20. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct 17; 17(97):179-82. PubMed ID: 19530373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.